BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 14695138)

  • 1. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
    Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
    Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic pathways of cell death induced by an interleukin-13 receptor-targeted recombinant cytotoxin in head and neck cancer cells.
    Kawakami M; Kawakami K; Puri RK
    Cancer Immunol Immunother; 2002 Feb; 50(12):691-700. PubMed ID: 11862421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interleukin-13 sensitivity and receptor phenotypes of human glial cell lines: non-neoplastic glia and low-grade astrocytoma differ from malignant glioma.
    Liu H; Jacobs BS; Liu J; Prayson RA; Estes ML; Barnett GH; Barna BP
    Cancer Immunol Immunother; 2000 Aug; 49(6):319-24. PubMed ID: 10946814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.
    Mintz A; Gibo DM; Slagle-Webb B; Christensen ND; Debinski W
    Neoplasia; 2002; 4(5):388-99. PubMed ID: 12192597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examining expression of folate receptor in squamous cell carcinoma of the head and neck as a target for a novel nanotherapeutic drug.
    Saba NF; Wang X; Müller S; Tighiouart M; Cho K; Nie S; Chen Z; Shin DM
    Head Neck; 2009 Apr; 31(4):475-81. PubMed ID: 19072997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of prostaglandin E by squamous carcinoma of the head and neck and adenocarcinoma of gastrointestinal tissue.
    Culo F; Klapan I; Katić V; Kolak T; Bakula B
    Med Oncol Tumor Pharmacother; 1992; 9(1):35-9. PubMed ID: 1341318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting and Sensitization of Breast Cancer Cells to Killing with a Novel Interleukin-13 Receptor α2-Specific Hybrid Cytolytic Peptide.
    Jannoo R; Walker W; Kanamarlapudi V
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive capacity of IL-8 expression in head and neck squamous carcinoma patients treated with radiotherapy or chemoradiotherapy.
    León X; García J; Farré N; Majercakova K; Avilés-Jurado FX; Quer M; Camacho M
    Acta Otorrinolaringol Esp (Engl Ed); 2020 Sep; ():. PubMed ID: 32972719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin-13 receptor α2 is associated with poor prognosis in patients with gastric cancer after gastrectomy.
    Lin C; Liu H; Zhang H; He H; Li H; Shen Z; Qin J; Qin X; Xu J; Sun Y
    Oncotarget; 2016 Aug; 7(31):49281-49288. PubMed ID: 27351230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
    Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
    Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A robust immune-related gene pairs signature for predicting the overall survival of esophageal cancer.
    Zheng W; Fang G; Huang Q; Shi D; Xie B
    BMC Genomics; 2023 Jul; 24(1):385. PubMed ID: 37430202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CAR Based Immunotherapy of Solid Tumours-A Clinically Based Review of Target Antigens.
    Maher J; Davies DM
    Biology (Basel); 2023 Feb; 12(2):. PubMed ID: 36829563
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Bhojnagarwala PS; O'Connell RP; Park D; Liaw K; Ali AR; Bordoloi D; Cassel J; Tursi NJ; Gary E; Weiner DB
    Mol Ther Oncolytics; 2022 Sep; 26():289-301. PubMed ID: 36090479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitinase 3-like 1 secreted from cancer-associated fibroblasts promotes tumor angiogenesis via interleukin-8 secretion in colorectal cancer.
    Watanabe K; Shiga K; Maeda A; Harata S; Yanagita T; Suzuki T; Ushigome H; Maeda Y; Hirokawa T; Ogawa R; Hara M; Takahashi H; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
    Int J Oncol; 2022 Jan; 60(1):. PubMed ID: 34913066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling and Characterization of Localized Cytokine Response in Congenital Cleft Affected Lip Tissue.
    Reiser SC; Tellermann J; Akota I; Pilmane M
    Life (Basel); 2021 Jun; 11(6):. PubMed ID: 34199238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Liver Metastasis in Colorectal Cancer by Targeting IL-13/IL13Rα2 Binding Site with Specific Monoclonal Antibodies.
    Jaén M; Bartolomé RA; Aizpurua C; Martin-Regalado Á; Imbaud JI; Casal JI
    Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33917458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Tyrosine Phosphatase-1B Inhibition Disrupts IL13Rα2-Promoted Invasion and Metastasis in Cancer Cells.
    Bartolomé RA; Martín-Regalado Á; Jaén M; Zannikou M; Zhang P; de Los Ríos V; Balyasnikova IV; Casal JI
    Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32098194
    [No Abstract]   [Full Text] [Related]  

  • 18. Transcriptional regulation of the IL-13Rα2 gene in human lung fibroblasts.
    Penke LR; Ouchi H; Speth JM; Lugogo N; Huang YJ; Huang SK; Peters-Golden M
    Sci Rep; 2020 Jan; 10(1):1083. PubMed ID: 31974428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activin A Signaling Regulates IL13Rα2 Expression to Promote Breast Cancer Metastasis.
    Kalli M; Mpekris F; Wong CK; Panagi M; Ozturk S; Thiagalingam S; Stylianopoulos T; Papageorgis P
    Front Oncol; 2019; 9():32. PubMed ID: 30805303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An IL13Rα2 peptide exhibits therapeutic activity against metastatic colorectal cancer.
    Bartolomé RA; Jaén M; Casal JI
    Br J Cancer; 2018 Oct; 119(8):940-949. PubMed ID: 30318506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.